DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vashishtha, S. C.
Right arrow Articles by Hogg, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vashishtha, S. C.
Right arrow Articles by Hogg, L.

Vol. 30, Issue 10, 1070-1076, October 2002

Quaternary Ammonium-Linked Glucuronidation of 1-Substituted Imidazoles by Liver Microsomes: Interspecies Differences and Structure-Metabolism Relationships

Sarvesh C. Vashishtha,1 Edward M. Hawes, Denis J. McCann,2 Omar Ghosheh, and Lawrence Hogg

Drug Metabolism and Drug Disposition Group (S.C.V., E.M.H., O.G., L.H.), University of Saskatchewan, and PharmaLytics (L.H.), Saskatoon, Saskatchewan, Canada; and Drug Disposition and Metabolism Department, AstraZeneca, Wilmington, DE (D.J.M.)

N-Glucuronidation at an aromatic tertiary amine of 5-membered polyaza ring systems was investigated for a model series of eight 1-substituted imidazoles in liver microsomes from five species. The major objectives were to investigate substrate specificities of the series in human microsomes and interspecies variation for the prototype molecule, 1-phenylimidazole. The formed quaternary ammonium-linked metabolites were characterized by positive ion electrospray mass spectrometry. The incubation conditions for the N-glucuronidation of 1-substituted imidazoles were optimized; where for membrane disrupting agents, alamethicin was more effective than the detergents examined. The need to optimize alamethicin concentration was indicated by 4-fold interspecies variation in optimal concentration and by a change in effect from removal of glucuronidation latency to inhibition on increasing concentration. For the four species with quantifiable N-glucuronidation of 1-phenylimidazole, there were 8- and 18-fold variations in the determined apparent Km (range, 0.63 to 4.8 mM) and Vmax (range, 0.08 to 1.4 nmol/min/mg of protein) values, respectively. The apparent clearance values (Vmax/Km) were in the following order: human congruent  guinea pig congruent  rabbit > rat congruent  dog (no metabolite detected). Monophasic kinetics were observed for the N-glucuronidation of seven substrates by human liver microsomes, which suggests that one enzyme is involved in each metabolic catalysis. No N-glucuronidation was observed for the substrate containing the para-phenyl substituent with the largest electron withdrawing effect, 1-(4-nitrophenyl)imidazole. Linear correlation analyses between apparent microsomal kinetics and substrate physicochemical parameters revealed significant correlations between Km and lipophilicity (pi para or log P values) and between Vmax/Km and both electronic properties (sigma para value) and pKa.


1 Current address: Wyeth Research, 500 Arcola Road, Collegeville, PA 19426-3930.

2 Current address: Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
Z. Yan, G. W. Caldwell, D. Gauthier, G. C. Leo, J. Mei, C. Y. Ho, W. J. Jones, J. A. Masucci, R. W. Tuman, R. A. Galemmo Jr., et al.
N-GLUCURONIDATION OF THE PLATELET-DERIVED GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR 6,7-(DIMETHOXY-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)-(3-FLUORO-PHENYL)-AMINE BY HUMAN UDP-GLUCURONOSYLTRANSFERASES
Drug Metab. Dispos., May 1, 2006; 34(5): 748 - 755.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Alonen, O. Aitio, K. Hakala, L. Luukkanen, M. Finel, and R. Kostiainen
BIOSYNTHESIS OF DOBUTAMINE MONOGLUCURONIDES AND GLUCURONIDATION OF DOBUTAMINE BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
Drug Metab. Dispos., May 1, 2005; 33(5): 657 - 663.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. G. Soars, B. J. Ring, and S. A. Wrighton
THE EFFECT OF INCUBATION CONDITIONS ON THE ENZYME KINETICS OF UDP-GLUCURONOSYLTRANSFERASES
Drug Metab. Dispos., June 1, 2003; 31(6): 762 - 767.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
O. Ghosheh and E. M. Hawes
Microsomal N-Glucuronidation of Nicotine and Cotinine: Human Hepatic Interindividual, Human Intertissue, and Interspecies Hepatic Variation
Drug Metab. Dispos., December 1, 2002; 30(12): 1478 - 1483.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.